FIELD: metabolic diseases. SUBSTANCE: to correct these conditions, effective amount of drug containing, as active ingredient, poly(2,5-dihydroxyphenylene)-4-sulfonic acid sodium salt is administered. Depending on its medicinal form, drug contains a variety of pharmaceutically acceptable auxiliary substances. EFFECT: extended reserve of indicated-destination drugs. 5 tbl, 3 ex
Authors
Dates
1999-01-20—Published
1997-06-25—Filed